ArticleBMC immunology2019

Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-μTP-L309C, a recombinant IgG1 Fc hexamer.

Bonnie J B Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.